arrow
R

Robert A. Holt

bc cancer research institute
H指数:123
被引数:15.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors

GPNMB导向的CAR T细胞疗法对抗MiT/TFE家族融合驱动型实体瘤

2026-07-010
PRE
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes
2024-04-262
OA
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies

CLIC-01: 非冻存CD19阳性恶性血液病car-t细胞制备与分布

2022-12-1911
OAAI
Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury
2021-12-2027
OAAI
Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

晚期实体瘤对免疫检查点抑制剂反应的基因组和转录组生物标志物

2021-01-0459
OAAI
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy

肿瘤浸润效应记忆抗原特异性CD8 T细胞预测对免疫检查点治疗的反应

2020-11-1249
OAAI
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes

晚期患者肿瘤的泛癌症分析揭示了治疗与基因组景观之间的相互作用

2020-04-1395
PREAI